JAN 21, 2021 12:00 PM PST

Injectable Cannabis Overdose Drug Being Developed

WRITTEN BY: Angela Dowden

It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and 2019, a period of time when recreational and medical cannabis was legalized across many states.

Heavy users may present with cannabis toxicity or cannabinoid hyperemesis syndrome, but so far there are no FDA approved drugs to treat acute overdoses of cannabis or synthetic cannabinoids like Spice and K2.

There have been case reports of successful treatment of with a continuous naloxone infusion, but a new drug is needed for acute cannabis overdose (ACO) and the award of an $850,000 grant from the National Center for Advancing Translational Sciences (NCATS) to contract development and manufacturing organization IRISYS LLC may now see this come to fruition.

San Diego-based IRISYS have been given the grant to develop an injectable form of a drug called drinabant, which binds to the same brain receptor as THC,  blocking its activity.

Drinabant is currently an investigational drug being developed by Opiant Pharmaceuticals, an NCATS collaborator, but orally ingested drinabant is absorbed too slowly to reverse the clinical manifestations of ACO.

The hope is that an injectable form of the drug will act more quickly to reverse the symptoms of ACO rapidly, thus limiting the time spent in an emergency room.

Symptoms of ACO include anxiety, feelings of paranoia, agitation, visual and auditory hallucinations, and nausea. The popularity of cannabis edibles is believed to be behind  increasing reports of acute overdose as they often contain much higher amounts of THC than available through smoking a joint. Edibles are usually in the form of brownies, cookies and candies, so young children are especially vulnerable because these may be easily mistaken for treats.

"The need to quickly and effectively reverse ACO symptoms, including in vulnerable populations like children, is a strong motivating factor pushing us at IRISYS every day to put in the effort needed to ensure that this drug is ready for clinical trials as soon as possible," stated Robert Giannini, Ph.D., IRISYS president and CSO/CTO.

Sources: Marijuana Business Daily, PR Newswire

 

 

About the Author
  • I'm a Journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
JAN 26, 2021
Immunology
Can we Stop Multiple Sclerosis Progression?!
JAN 26, 2021
Can we Stop Multiple Sclerosis Progression?!
Multiple sclerosis is known for its progression of symptoms even after a period of complete remission. There is no way o ...
JAN 25, 2021
Cardiology
Obesity's Poor Health Impact Not Overcome by Exercise
JAN 25, 2021
Obesity's Poor Health Impact Not Overcome by Exercise
While there has been limited evidence that activity and fitness can counter the health impacts of excess body fat, a new ...
FEB 09, 2021
Cell & Molecular Biology
Brain Cells Called Astrocytes Linked to Depression
FEB 09, 2021
Brain Cells Called Astrocytes Linked to Depression
Depression is thought to affect at least 264 million people of all ages worldwide, and the available treatment options d ...
FEB 11, 2021
Health & Medicine
Post-EVALI Investigation by Leafly Reveals Inadequate Cannabis Vape Controls
FEB 11, 2021
Post-EVALI Investigation by Leafly Reveals Inadequate Cannabis Vape Controls
Cannabis website Leafly has published the results of their probe into vape rules following the EVALI (e-cigarette or vap ...
FEB 22, 2021
Cell & Molecular Biology
How an Organelle Makes Its Own Proteins
FEB 22, 2021
How an Organelle Makes Its Own Proteins
Inside of cells, organelles perform specialized functions to keep biological functions moving, one of which is the ribos ...
FEB 25, 2021
Clinical & Molecular DX
A Better Way to Triage COVID Patients
FEB 25, 2021
A Better Way to Triage COVID Patients
Australian researchers have developed a COVID-19 triaging tool that serves as a crystal ball for healthcare workers. Onc ...
Loading Comments...